Search

everythinglearnresearchcommunity

for

Search:↓

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

PCOS causes hormonal imbalance, leading to symptoms like irregular periods and infertility.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Hormonal therapies effectively treat acne and improve quality of life.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Pediatricians should advise sexually active teens on safe sex and STD prevention, and discuss contraceptive options and their side effects.

PCOS patients have higher LDH and lower cortisol, dopamine, zinc, and vitamin D3, which may contribute to their symptoms and obesity.

Women with PCOS have altered brain structure and reduced cognitive performance.

No treatment showed significant long-term hair growth benefits for alopecia areata.